GlassScriptPhysician profile
Jennifer Planitz
NPI 1184785784
$6,929.05
in general payments reported to CMS, 2019-2025
20 companies · $902 in 2025
The $902 reported for 2025 was more than what 94% of Occupational Vision providers received nationally (typical 2025 total: $169).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $990 · 2020: $896 · 2021: $896 · 2022: $768 · 2023: $843 · 2024: $1,636 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,076 · Entertainment: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,075.99 |
| Entertainment | $304.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,086.23 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Lumenis Be INC | $1,130.55 | 2023-2024 | M22 |
| Bausch & Lomb Americas INC. | $840.28 | 2022-2025 | Infuse, Biotrue One Day |
| Optos, INC. | $526.42 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $374.47 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $321.47 | 2019-2021 | |
| Alcon Vision LLC | $313.85 | 2020-2025 | Precision7 |
| Sight Sciences, INC. | $245.55 | 2022-2023 | Tearcare System |
| Topcon Healthcare, INC. | $140.55 | 2025 | |
| Abb Con-Cise Optical Group LLC | $136.36 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $124.83 | 2020 | |
| Galderma Laboratories, L.P. | $122.89 | 2023 | |
| Novartis Pharmaceuticals Corporation | $118.44 | 2021 | |
| Apellis Pharmaceuticals, INC. | $108.75 | 2023 | Syfovre |
| Johnson & Johnson Surgical Vision, INC. | $93.89 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $83.76 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $75.10 | 2019 | |
| Allergan, INC. | $46.24 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $21.49 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Planitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.